首页> 外国专利> Substituted 1,2-Dihydroquinoline-N-Carboxylic Acids and -Thioncarboxylic Acids

Substituted 1,2-Dihydroquinoline-N-Carboxylic Acids and -Thioncarboxylic Acids

机译:取代的1,2-二氢喹啉-N-羧酸和-硫代羧酸

摘要

1,158,264. Substituted 1,2-dihydroquinoline- N-carboxylic and -thioncarboxylic acids. BRISTOL-MYERS CO. 12 Oct., 1966 [13 Oct., 1965], No. 45586/66. Heading C2C. Novel substituted 1,2-dihydroquinoline-N- carboxylic and -thioncarboxylic acids of the general formula wherein RSP1/SP, RSP2/SP and RSP3/SP are each hydrogen, chloro, bromo, iodo, fluoro, trifluoromethyl, C 1-6 alkyl, C 1 _ 6 alkoxy, C 1-6 alkylthio, C 1 _ 6 alkylsulphonyl, hydroxy, C 1 _ 6 alkanoyloxy, amino, alkoxycarbonylamino or a group of the formula (C 1 _ 6 alkyl) 2 N(CH 2 ) n - in which n is 0 or an integer from 1 to 3 inclusive, X is oxygen or sulphur, and RSP4/SP is a monovalent non- aromatic radical containing only carbon and hydrogen and having less than eleven carbon atoms, halo-C 1-6 alkyl other than α-haloalkyl,or aralkyl, and non-toxic, pharmaceutically acceptable acid addition salts thereof are prepared by reaction of a compound of the general formula X = CZ-O-RSP4/SP, wherein Z is a chlorine, bromine or iodine atom, with (a) a 1,2-dihydroquinoline of the general formula or (b) a quinoline of the general formula followed by reduction with an alkali metal borohydride; followed by optional conversion of the product to a non-toxic, pharmaceutically acceptable acid addition salt thereof. 1,2-Dihydroquinolines of the second general formula above are prepared by reduction of quinolines of the third general formula above. 5-Aminoquinoline is prepared by the hydrazine- Raney nickel reduction of 5-nitroquinoline. 1 - Ethoxycarbonyl - 5 - isocyanato - 1,2 - dihydroquinoline is prepared by distillation under vacuum of 1 -ethoxycarbonyl - 5 -ethoxycarbonylamino- 1,2-dihydroquinoline. Pharmaceutical compositions having analgesic, tranquilizing, sedative, depressant, anorexic and hypotensive activity comprise, as active ingredient, a substituted 1,2-dihydroquinoline- N-carboxylic or -thioncarboxylie acid of the first general formula above or a non-toxic, pharmaceutically acceptable acid addition salt thereof, together with an inert diluent or carrier.
机译:1,158,264。取代的1,2-二氢喹啉-N-羧酸和-亚硫代羧酸。 BRISTOL-MYERS CO。,1966年10月12日[1965年10月13日],第45586/66号。标题C2C。具有通式的新型取代的1,2-二氢喹啉-N-羧酸和-亚硫羧酸,其中R 1 ,R 2 和R 3 每个氢,氯,溴,碘,氟,三氟甲基,C 1-6烷基,C 1-6烷氧基,C 1-6烷硫基,C 1-6烷基磺酰基,羟基,C 1-6烷酰氧基,氨基,烷氧基羰基氨基或式(C 1 _ 6烷基)2 N(CH 2)n-的基团,其中n为0或1至3的整数,X为氧或硫,R 4 为通过反应制备仅含碳和氢且具有少于十一个碳原子的单价非芳族基团,除α-卤代烷基以外的卤代C 1-6烷基或芳烷基,以及其无毒的药学上可接受的酸加成盐通式X = CZ-OR 4 的化合物,其中Z是氯,溴或碘原子,与(a)通式1,2-二氢喹啉或(b)通式的喹啉,然后用碱金属硼氢化物;然后将产物任选转化为其无毒的药学上可接受的酸加成盐。通过还原以上第三通式的喹啉来制备以上第二通式的1,2-二氢喹啉。 5-氨基喹啉是通过将5-硝基喹啉的肼-阮内镍还原而制备的。通过在真空下蒸馏1-乙氧基羰基-5-乙氧基羰基氨基-1,2-二氢喹啉来制备1-乙氧基羰基-5-异氰酸根合基1-2,二氢喹啉。具有镇痛,镇静,镇静,镇静,镇痛,厌食和降压活性的药物组合物包含上述第一通式的取代的1,2-二氢喹啉-N-羧酸或-亚硫代羧酸或无毒的药学上可接受的成分作为活性成分其酸加成盐,以及惰性稀释剂或载体。

著录项

  • 公开/公告号GB1158264A

    专利类型

  • 公开/公告日1969-07-16

    原文格式PDF

  • 申请/专利权人 BRISTOL-MYERS COMPANY;

    申请/专利号GB19660045586

  • 申请日1966-10-12

  • 分类号C07D215/06;C07D215/08;C07D215/12;C07D215/18;C07D215/20;C07D215/36;C07D215/38;C07D215/48;

  • 国家 GB

  • 入库时间 2022-08-23 11:50:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号